Research on the vitamin D binding protein gene polymorphism in elderly patients with stable chronic obstructive pulmonary disease
10.3760/cma.j.issn.0254-9026.2019.12.007
- VernacularTitle: 老年人慢性阻塞性肺疾病稳定期维生素D结合蛋白基因多态性研究
- Author:
Huanhuan JIANG
1
;
Chenci JIN
1
;
Sunshun YAN
2
;
Qiong CHI
3
;
Jian ZHENG
4
;
Longxiang JIANG
1
;
Ningning YU
1
Author Information
1. Department of Respiratory Medicine, Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine, Wenzhou 325000, China
2. Department of Respiratory Medicine, the 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China
3. Department of Respiratory Medicine, Wenzhou Central Hospital, Wenzhou 325000, China
4. Department of Respiratory Medicine, Wenzhou Yongjia County Hospital of Traditional Chinese Medicine, Wenzhou 325100, China
- Publication Type:Journal Article
- Keywords:
Vitamin D binding protein;
Polymorphism, Single nucleotide;
Pulmonary disease, chronic obstructive
- From:
Chinese Journal of Geriatrics
2019;38(12):1348-1352
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To discuss the correlation between the effect of vitamin D treatment and vitamin D binding protein gene polymorphism in elderly patients with stable chronic obstructive pulmonary disease(COPD).
Methods:A total of 800 elderly patients with stable COPD admitted to the four Departments of Respiratory Medicine of four Wenzhou Hospitals were enrolled from September 2016 to November 2018.Because of the drop-out during follow-up, there were final 776 patients in our prospective research.According to the GC gene type, patients were divided into the GC1F-1S(n=214), the GC1F-1S(n=168), GC1F-2(n=160), GC1S-1S(n=132), GC1F-2(n=82)and GC2-2 groups(n=44), and each group was randomly divided into control group(n=400)receiving the conventional treatment and the treatment group(n=400)taking vitmain D 0.5 μg/d for 3 months as add-on to the conventional treatment.The lung function and the COPD assessment test(CAT)score before and after the therapy were observed and compared in patients with different GC sub-genotypes.
Results:Among the elderly patients enrolled in our research, GC1F-1F genotype was most common, accounting for 26.8%(214 cases), the followings of next order were GC 1F-1S genotype accounting for 21.0%(168 cases), and GC2-2 genotype was most rare, accounting for 5.5%(44 cases). The lung function were improved and the CAT score were reduced in all groups after therapy as compared with pre-treatment(P<0.05). The lung function was better and the CAT score was lower in patients with GC1F-1F, GC1F-1S, GC1F-2, GC1S-1S sub-genotypes(13.77±4.67 vs.15.83±3.73, 15.38±4.45 vs.17.86±3.92, 17.42±3.19 vs.19.46±4.07)than in the corresponding control subgroups after treatment(P<0.05). While, there was no significant difference in the lung function and the CAT score between patients with GC1S-2 and GC2-2 genotypes in control versus treatment subgroups(P>0.05).
Conclusions:Vitamin D binding protein gene polymorphism is associated with the curative effect of supplement of vitamin D in elderly patients with stable COPD, which has a predictive value for the curative effect of vitamin D supplement.
